{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:20:49Z","timestamp":1788168049378,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"MSH Medical School Hamburg - University of Applied Sciences and Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Hintergrund<\/jats:title>\n                    <jats:p>Menschen mit nichtdialysepflichtiger chronischer Nierenerkrankung (\u201enon-dialysis chronic kidney disease\u201c [ND-CKD]) berichten h\u00e4ufig eine hohe k\u00f6rperliche Symptombelastung. Traditionelle klinische Ans\u00e4tze postulieren eine hohe Symptombelastung erst in sp\u00e4ten Stadien.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Fragestellung<\/jats:title>\n                    <jats:p>Diese Studie vergleicht die Symptombelastung bei ND-CKD aus \u00e4rztlicher Sicht mit der Patientenperspektive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material und Methoden<\/jats:title>\n                    <jats:p>In einer deutschlandweiten Onlinebefragung benannten Nephrologinnen und Nephrologen die drei h\u00e4ufigsten Symptome sowie die durchschnittliche Symptombelastung bei chronischer Nierenerkrankung (\u201echronic kidney disease\u201c [CKD]) mithilfe einer adaptierten Version des Chronic Kidney Disease Symptom Burden Index (CKD-SBI). Die Ergebnisse wurden mit Selbstausk\u00fcnften im CKD-SBI von Personen der SOMA.CK-Studie mit ND-CKD verglichen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ergebnisse<\/jats:title>\n                    <jats:p>\n                      Einsch\u00e4tzungen zur Symptombelastung von\n                      <jats:italic>N<\/jats:italic>\n                      \u202f=\u2009108 Nephrologinnen und Nephrologen (durchschnittliche Berufserfahrung: 14,3 Jahre) wurden mit den Angaben von\n                      <jats:italic>N<\/jats:italic>\n                      \u202f=\u2009222 Personen mit ND-CKD (Durchschnittsalter\u202f=\u200961,22 Jahre, Standardabweichung [SD]\u202f=\u200914,90) verglichen. Nephrologinnen und Nephrologen nannten Fatigue (69,44\u202f%), \u00d6deme (38,89\u202f%) und arterielle Hypertonie (35,19\u202f%) am h\u00e4ufigsten, w\u00e4hrend Betroffene Unterbrechung des Nachtschlafs durch Harndrang (74,30\u202f%), Fatigue (61,30\u202f%) und Schlafprobleme (47,30\u202f%) angaben. Nephrologinnen und Nephrologen \u00fcbersch\u00e4tzten sowohl die Gesamtsymptombelastung als auch die Symptombelastung von 5\u00a0Einzelsymptomen signifikant, w\u00e4hrend sie die von 12\u00a0Einzelsymptomen unter- und die von 15\u00a0Einzelsymptomen vergleichbar einsch\u00e4tzten.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Schlussfolgerung<\/jats:title>\n                    <jats:p>Eine Diskrepanz zwischen \u00e4rztlich eingesch\u00e4tzter und patientenberichteter Symptombelastung bei ND-CKD wird deutlich. Die Ergebnisse st\u00fctzen die Empfehlung, die Betroffenenperspektive in der Symptomerfassung st\u00e4rker zu ber\u00fccksichtigen.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00108-026-02155-9","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:32:50Z","timestamp":1784701970000},"page":"1025-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Symptombelastung bei chronischer Nierenerkrankung\u00a0\u2013 nephrologische Einsch\u00e4tzung im Vergleich zur Betroffenenperspektive (SOMA.CK-Studie)","Symptom burden in chronic kidney disease\u2014nephrological assessment compared to patients\u2019 perspectives (SOMA.CK study)"],"prefix":"10.1007","volume":"67","author":[{"given":"Birte","family":"Jessen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"L\u00f6we","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schmidt-Lauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Shedden-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2155_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0036-2","volume":"16","author":"H Almutary","year":"2015","unstructured":"Almutary\u00a0H, Bonner\u00a0A, Douglas\u00a0C (2015) Arabic translation, adaptation and modification of the Dialysis Symptom Index for chronic kidney disease stages four and five. BMC Nephrol 16:36","journal-title":"BMC Nephrol"},{"key":"2155_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/jorc.12152","volume":"42","author":"H Almutary","year":"2016","unstructured":"Almutary\u00a0H, Bonner\u00a0A, Douglas\u00a0C (2016) Which patients with chronic kidney disease have the greatest symptom burden? A comparative study of advanced CKD stage and dialysis modality. Journal of renal care 42:73\u201382","journal-title":"Journal of renal care"},{"key":"2155_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/ckj\/sfx057","volume":"10","author":"SA Brown","year":"2017","unstructured":"Brown\u00a0SA, Tyrer\u00a0FC, Clarke\u00a0AL et\u00a0al (2017) Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy. Clinical Kidney Journal 10:788\u2013796","journal-title":"Clinical Kidney Journal"},{"key":"2155_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpainsymman.2009.07.003","volume":"39","author":"RN Claxton","year":"2010","unstructured":"Claxton\u00a0RN, Blackhall\u00a0L, Weisbord\u00a0S (2010) Undertreatment of Symptoms in Patients on Maintenance Hemodialysis. Journal of Pain and Symptom Management 39:211\u2013217","journal-title":"Journal of Pain and Symptom Management"},{"key":"2155_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2024.151546","volume":"44","author":"SN Davison","year":"2024","unstructured":"Davison\u00a0SN, Richardson\u00a0MM, Roberts\u00a0GV (2024) Measuring Symptoms Across the Spectrum of Chronic Kidney Disease: Strategies for Incorporation Into Kidney Care. Semin Nephrol 44:151546","journal-title":"Semin Nephrol"},{"key":"2155_CR6","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2215\/CJN.01840220","volume":"15","author":"JM Evans","year":"2020","unstructured":"Evans\u00a0JM, Glazer\u00a0A, Lum\u00a0R et\u00a0al (2020) Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care: Perspectives of Patients and Providers on ESAS-r:Renal. Clin J Am Soc Nephrol 15:1299\u20131309","journal-title":"Clin J Am Soc Nephrol"},{"key":"2155_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003954","volume":"19","author":"BR Fletcher","year":"2022","unstructured":"Fletcher\u00a0BR, Damery\u00a0S, Aiyegbusi\u00a0OL et\u00a0al (2022) Symptom burden and health-related quality of life in chronic kidney disease: A\u00a0global systematic review and meta-analysis. PLoS Medicine 19:e1003954","journal-title":"PLoS Medicine"},{"key":"2155_CR8","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker\u00a0LA, Eneanya\u00a0ND, Coresh\u00a0J et\u00a0al (2021) New Creatinine- and Cystatin C\u2011Based Equations to Estimate GFR without Race. N Engl J Med 385:1737\u20131749","journal-title":"N Engl J Med"},{"key":"2155_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41581-021-00518-z","volume":"18","author":"K Kalantar-Zadeh","year":"2022","unstructured":"Kalantar-Zadeh\u00a0K, Lockwood\u00a0MB, Rhee\u00a0CM et\u00a0al (2022) Patient-centred approaches for the management of unpleasant symptoms in kidney disease. Nat Rev Nephrol 18:185\u2013198","journal-title":"Nat Rev Nephrol"},{"key":"2155_CR10","doi-asserted-by":"crossref","unstructured":"Kdigo (2024) KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International 105","DOI":"10.1016\/j.kint.2023.09.002"},{"key":"2155_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057596","volume":"12","author":"B L\u00f6we","year":"2022","unstructured":"L\u00f6we\u00a0B, Andresen\u00a0V, Van Den Bergh\u00a0O et\u00a0al (2022) Persistent SOMAtic symptoms ACROSS diseases - from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211). BMJ Open 12:e057596","journal-title":"BMJ Open"},{"key":"2155_CR12","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/S0140-6736(24)00623-8","volume":"403","author":"B L\u00f6we","year":"2024","unstructured":"L\u00f6we\u00a0B, Toussaint\u00a0A, Rosmalen\u00a0JGM et\u00a0al (2024) Persistent physical symptoms: definition, genesis, and management. The Lancet 403:2649\u20132662","journal-title":"The Lancet"},{"key":"2155_CR13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41375-025-02524-7","volume":"39","author":"K Manz","year":"2025","unstructured":"Manz\u00a0K, Heidel\u00a0FH, Koschmieder\u00a0S et\u00a0al (2025) Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN). Leukemia 39:864\u2013875","journal-title":"Leukemia"},{"key":"2155_CR14","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.ekir.2023.08.025","volume":"8","author":"MSN Ng","year":"2023","unstructured":"Ng\u00a0MSN, Brown\u00a0EA, Cheung\u00a0M et\u00a0al (2023) The Role of Nephrology Nurses in Symptom Management - Reflections on the Kidney Disease: Improving Global Outcomes Controversies Conference on Symptom-Based Complications in Dialysis Care. Kidney Int Rep 8:1903\u20131906","journal-title":"Kidney Int Rep"},{"key":"2155_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2025.101220","volume":"8","author":"DM Patel","year":"2026","unstructured":"Patel\u00a0DM, Panda\u00a0A, Fatima\u00a0S et\u00a0al (2026) Patient and Physician Perspectives on Use of Patient-Reported Outcome Measures in Non-Dialysis-Dependent CKD Care: A Qualitative Study. Kidney Med 8:101220","journal-title":"Kidney Med"},{"key":"2155_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jorc.12208","volume":"43","author":"K Pugh-Clarke","year":"2017","unstructured":"Pugh-Clarke\u00a0K, Read\u00a0SC, Sim\u00a0J (2017) Symptom experience in non-dialysis-dependent chronic kidney disease: A\u00a0qualitative descriptive study. J\u00a0Ren Care 43:197\u2013208","journal-title":"J Ren Care"},{"key":"2155_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/nep.12754","volume":"22","author":"R Raj","year":"2017","unstructured":"Raj\u00a0R, Ahuja\u00a0KD, Frandsen\u00a0M et\u00a0al (2017) Symptoms and their recognition in adult haemodialysis patients: Interactions with quality of life. Nephrology (Carlton) 22:228\u2013233","journal-title":"Nephrology (Carlton)"},{"key":"2155_CR18","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.ekir.2022.06.015","volume":"7","author":"CM Rhee","year":"2022","unstructured":"Rhee\u00a0CM, Edwards\u00a0D, Ahdoot\u00a0RS et\u00a0al (2022) Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference Proceedings. Kidney Int Rep 7:1951\u20131963","journal-title":"Kidney Int Rep"},{"key":"2155_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07836-x","volume":"31","author":"A Ribbands","year":"2023","unstructured":"Ribbands\u00a0A, Boytsov\u00a0N, Bailey\u00a0A et\u00a0al (2023) Real-world patient-reported outcomes and concordance between patient and physician reporting of side effects across lines of therapy in multiple myeloma within the USA. Support Care Cancer 31:371","journal-title":"Support Care Cancer"},{"key":"2155_CR20","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/ndt\/gfaf075","volume":"40","author":"C Schmidt-Lauber","year":"2025","unstructured":"Schmidt-Lauber\u00a0C, Thompson\u00a0C, Alba Schmidt\u00a0E et\u00a0al (2025) Prevalence and characteristics of chronic kidney disease in the Hamburg City Health Study. Nephrol Dial Transplant 40:1632\u20131634","journal-title":"Nephrol Dial Transplant"},{"key":"2155_CR21","doi-asserted-by":"crossref","unstructured":"Shedden-Mora M, Jessen B, Huber TB (2024) Why Symptom Burden in Non-Dialysis CKD Matters. Am J Kidney Dis","DOI":"10.1053\/j.ajkd.2024.07.005"},{"key":"2155_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067821","volume":"12","author":"MC Shedden-Mora","year":"2022","unstructured":"Shedden-Mora\u00a0MC, Jessen\u00a0B, Schmidt-Lauber\u00a0C et\u00a0al (2022) Predictors of somatic symptom persistence in patients with chronic kidney disease (SOMA.CK): study protocol for a\u00a0mixed-methods cohort study. BMJ Open 12:e067821","journal-title":"BMJ Open"},{"key":"2155_CR23","doi-asserted-by":"crossref","unstructured":"Speyer E, Tu C, Zee J et\u00a0al. (2024) Symptom Burden and Its Impact on Quality of Life in Patients With Moderate to Severe CKD: The International Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps). Am J Kidney Dis","DOI":"10.1053\/j.ajkd.2024.06.011"},{"key":"2155_CR24","unstructured":"Tivian (2025) Marktf\u00fchrende Experience-Management-Software von Tivian. https:\/\/www.tivian.com\/de\/. Zugegriffen: 30.\u00a0Mai 2025"},{"key":"2155_CR25","doi-asserted-by":"publisher","first-page":"20906","DOI":"10.1002\/cam4.6632","volume":"12","author":"S Umashankar","year":"2023","unstructured":"Umashankar\u00a0S, Basu\u00a0A, Esserman\u00a0L et\u00a0al (2023) Concordance between patient-reported and physician-documented comorbidities and symptoms among Stage 4 breast cancer patients. Cancer Med 12:20906\u201320917","journal-title":"Cancer Med"},{"key":"2155_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1053\/j.ackd.2007.07.004","volume":"14","author":"SD Weisbord","year":"2007","unstructured":"Weisbord\u00a0SD (2007) Symptoms and their correlates in chronic kidney disease. Advances in chronic kidney disease 14:319\u2013327","journal-title":"Advances in chronic kidney disease"},{"key":"2155_CR27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2215\/CJN.00990207","volume":"2","author":"SD Weisbord","year":"2007","unstructured":"Weisbord\u00a0SD, Fried\u00a0LF, Mor\u00a0MK et\u00a0al (2007) Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clinical Journal of the American Society of Nephrology 2:960\u2013967","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"2155_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2025.101011","volume":"7","author":"KE Wulczyn","year":"2025","unstructured":"Wulczyn\u00a0KE, Liu\u00a0A, Lash\u00a0JP et\u00a0al (2025) Patient-Reported Symptoms Compared With Nephrologist Documentation During Outpatient Visits: A Retrospective Patient-Reported Outcome Measures Study. Kidney Med 7:101011","journal-title":"Kidney Med"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02155-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02155-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02155-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:49:08Z","timestamp":1788166148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02155-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2155"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02155-9","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"23 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Als Teil der SOMA.CK-Studie wurde diese Studie durch die Deutsche Forschungsgemeinschaft (DFG) finanziert (Studienleitung: M.\u00a0Shedden-Mora und T.B.\u00a0Huber; Projektnummer: 445297796). SOMA.CK ist Teil der Forschungsgemeinschaft RU 5211 \u201ePersistent SOMAtic symptoms ACROSS diseases: from risk factors to modification\u201c (SOMACROSS), finanziert durch die DFG (Sprecher: B.\u00a0L\u00f6we). B.\u00a0Jessen erhielt zudem einen Mini Grant f\u00fcr die deutschlandweite Rekrutierung von Nephrologinnen und Nephrologen. Die F\u00f6rderung erfolgte institutionell \u00fcber die Medical School Hamburg (MSH) und das Universit\u00e4tsklinikum Hamburg-Eppendorf. Zudem wurden Reise- und Kongresskosten mit inhaltlichem Bezug zur Studie durch die DFG unterst\u00fctzt. C.\u00a0Schmidt-Lauber gibt an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}